Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, vol.15, p.28930295, 2018. ,
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome, Lancet Diabetes Endocrinol, vol.2, p.24731669, 2014. ,
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, p.26707365, 2016. ,
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, vol.115, p.15864352, 2005. ,
Liver fat in the metabolic syndrome, J Clin Endocrinol Metab, vol.92, p.17595248, 2007. ,
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis, J Gastroenterol Hepatol, vol.31, p.26667191, 2016. ,
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study, Hepatology, vol.57, p.23213066, 2013. ,
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, vol.10, p.23507799, 2013. ,
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population, BMC Gastroenterol, vol.6, p.17081293, 2006. ,
External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross sectional study in Taiwan, PLoS ONE, vol.10, issue.3, p.25781622, 2015. ,
External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study, Clin Gastroenterol Hepatol, vol.11, p.23353640, 2013. ,
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population, Hepatology, vol.49, p.19291789, 2009. ,
Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study, Diabetes Care, vol.34, p.21278140, 2011. ,
Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes, J Diabetes Investig, vol.6, p.25969716, 2015. ,
Fatty liver index is a predictor of incident diabetes in patients with prediabetes: the PREDAPS study, PLoS ONE, vol.13, issue.6, p.29856820, 2018. ,
The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care, vol.26, p.12610029, 2003. ,
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.28, issue.7, p.3899825, 1985. ,
IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition, The Lancet, vol.366, issue.9491, pp.1059-1062, 2005. ,
, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes, Diabetes Care, vol.41, p.29222373, 2018.
NAFLD and diabetes mellitus, Nat Rev Gastroenterol Hepatol, vol.14, p.27729660, 2017. ,
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease, Gastroenterology, vol.135, p.19010326, 2008. ,
Gamma-glutamyltransferase and diabetes-a 4 year follow-up study, Diabetologia, vol.46, p.12687334, 2003. ,
Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis, Diabetes Care, vol.32, p.19131466, 2009. ,
Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults, Diabet Med, vol.25, p.18346164, 2008. ,
,
Nine-year incident diabetes is predicted by fatty liver indices: the French D, E.S.I.R. study. BMC Gastroenterol, vol.10, p.20529259, 2010. ,
Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study, PLoS One, vol.10, p.25902304, 2015. ,
, Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019, Diabetes Care, vol.42, pp.29-33, 2019.
Resolution of fatty liver and risk of incident diabetes, J Clin Endocrinol Metab, vol.98, p.23873989, 2013. ,